HNGE reports Rule 144 notice, RSUs and 10b5-1 sales

Hinge Health (HNGE) filing a Rule 144 notice reports proposed and recent sales of Common stock tied to restricted stock units and executed 10b5-1 plans.

Rhea-AI Filing Summary

Hinge Health (HNGE) filing a Rule 144 notice reports proposed and recent sales of Common stock tied to restricted stock units and executed 10b5-1 plans. The filing lists 300,001 Restricted Stock Units with an 05/21/2025 grant date and multiple 10b5-1 sales in 2026 totaling 250, - (see detailed sale rows).

The notice itemizes three completed 10b5-1 trades: 33,333 shares on 04/21/2026, 50,000 shares on 04/01/2026, and 166,666 shares on 03/06/2026, with proceeds shown per trade.

Insights

Securities Compliance Attorney

Rule 144 notice lists planned RSU disposition and recent 10b5-1 sales by the reporting party.

The filing documents proposed sales of 300,001 Restricted Stock Units (grant date 05/21/2025) and three executed 10b5-1 sale transactions in Q1–Q2 2026 with per-trade proceeds recorded.

These entries appear procedural: they list grant counts, specific sale dates, share counts, and proceeds. Cash-flow treatment and remaining holdings are not detailed in the excerpt; subsequent filings or Rule 4 notices may disclose post-transaction positions.

Key Figures

Restricted Stock Units listed: 300,001 10b5-1 sale on 03/06/2026: 166,666 shares Proceeds for 03/06/2026 sale: $7,552,653.25 +4 more

7 metrics

Restricted Stock Units listed 300,001 Securities To Be Sold line, grant date 05/21/2025

10b5-1 sale on 03/06/2026 166,666 shares 10b5-1 Sales row dated 03/06/2026

Proceeds for 03/06/2026 sale $7,552,653.25 Proceeds listed for 166,666-share sale on 03/06/2026

10b5-1 sale on 04/01/2026 50,000 shares 10b5-1 Sales row dated 04/01/2026

Proceeds for 04/01/2026 sale $1,922,780.00 Proceeds listed for 50,000-share sale on 04/01/2026

10b5-1 sale on 04/21/2026 33,333 shares 10b5-1 Sales row dated 04/21/2026

Proceeds for 04/21/2026 sale $1,501,528.32 Proceeds listed for 33,333-share sale on 04/21/2026

Key Terms

Rule 144, Restricted Stock Units, 10b5-1

3 terms

Rule 144 regulatory

"Rule 144 notice reports proposed and recent sales of Common stock"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Restricted Stock Units financial

"Securities To Be Sold | Restricted Stock Units | Issuer"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

10b5-1 regulatory

"10b5-1 Sales for GABRIEL MECKLENBURG ... with share counts and proceeds"

A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Hinge Health's (HNGE) Form 144 disclose?

The form discloses proposed and recent sales of Common stock tied to RSUs. It lists 300,001 Restricted Stock Units (grant date 05/21/2025) and three 10b5-1 sales in 2026 with share counts and proceeds recorded.

How many shares were sold under 10b5-1 plans in the filing?

The filing lists three 10b5-1 sales: 166,666, 50,000, and 33,333 shares on 03/06/2026, 04/01/2026, and 04/21/2026 respectively, with proceeds shown for each trade.

What proceeds are reported for the recent 10b5-1 sales?

Proceeds are recorded per trade: $7,552,653.25 for 166,666 shares, $1,922,780.00 for 50,000 shares, and $1,501,528.32 for 33,333 shares, as shown in the filing rows.

Does the filing state who received the sale proceeds?

The excerpt lists trades executed under 10b5-1 plans but does not state the recipient of proceeds. The seller is identified in sale rows; explicit cash‑flow party attribution is not provided in the excerpt.

Are the listed Restricted Stock Units already vested or issuable?

The filing shows 300,001 Restricted Stock Units with grant date 05/21/2025 and labels them as 'Restricted Stock Units'. Vesting status or issuance timing is not specified in the provided excerpt.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/06/2026 - 04:24 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002062781
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Hinge Health, Inc.
SEC File Number	001-42657
Address of Issuer	455 Market Street, Suite 700 San Francisco CALIFORNIA 94105
Phone	4157262206
Name of Person for Whose Account the Securities are To Be Sold	GABRIEL MECKLENBURG
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director
Relationship to Issuer	Exec. Chairman & Co-Founder

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	300001	14925049.75	55816216	05/06/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/21/2025	Restricted Stock Units	Issuer			300001	05/21/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for GABRIEL MECKLENBURG 455 Market Street, Suite 700 San Francisco CA 94105	Common	04/21/2026	33333	1501528.32
10b5-1 Sales for GABRIEL MECKLENBURG 455 Market Street, Suite 700 San Francisco CA 94105	Common	04/01/2026	50000	1922780.00
10b5-1 Sales for GABRIEL MECKLENBURG 455 Market Street, Suite 700 San Francisco CA 94105	Common	03/06/2026	166666	7552653.25

144: Remarks and Signature

Remarks
Date of Notice	05/06/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	12/01/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Gabriel Mecklenburg
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)